Nanogroup SA
Research Nanogroup SA (NNG) on Bullrun: market cap PLN 105.08M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNNG
- ExchangeWAR
- CountryPoland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyPLN
- Market capPLN 105.08M
- Financial periodQ1 2026
- RevenuePLN 0
- Net income-PLN 2.24M
- Free cash flow-PLN 3.65M
Valuation Snapshot
latest market cap is PLN 105.08M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | PLN 105.08M | n/a | n/a | n/a |
About Nanogroup SA
NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantation. NanoGroup S.A.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nanogroup SA's market cap?
Nanogroup SA's market capitalization is PLN 105.08M.
What does Nanogroup SA do?
NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantation. NanoGroup S.A. was incorporated in 2016 and is based in Warsaw, Poland.